2021年最新SCI期刊影响因子查询系统
JOURNAL OF GENE MEDICINE 期刊详细信息
基本信息
期刊名称 | JOURNAL OF GENE MEDICINE JOURNAL OF GENE MEDICINE |
---|---|
期刊ISSN | 1099-498X |
期刊官方网站 | http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1521-2254 |
是否OA | 否 |
出版商 | John Wiley and Sons Ltd |
出版周期 | Monthly |
始发年份 | 1999 |
年文章数 | 46 |
最新影响因子 | 4.152(2021) |
中科院SCI期刊分区
大类学科 | 小类学科 | Top | 综述 |
---|---|---|---|
医学4区 | BIOTECHNOLOGY & APPLIED MICROBIOLOGY 生物工程与应用微生物4区 | 否 | 否 |
GENETICS & HEREDITY 遗传学4区 | |||
MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验4区 |
CiteScore
CiteScore排名 | CiteScore | SJR | SNIP | ||
---|---|---|---|---|---|
学科 | 排名 | 百分位 | 1.49 | 0.480 | 0.448 |
Medicine Genetics(clinical) |
69 / 91 | 24% |
|||
Pharmacology, Toxicology and Pharmaceutics Drug Discovery |
94 / 146 | 35% |
|||
Biochemistry, Genetics and Molecular Biology Molecular Medicine |
125 / 165 | 24% |
|||
Biochemistry, Genetics and Molecular Biology Genetics |
228 / 318 | 28% |
|||
Biochemistry, Genetics and Molecular Biology Molecular Biology |
305 / 375 | 18% |
补充信息
自引率 | 3.90% |
---|---|
H-index | 84 |
SCI收录状况 |
Science Citation Index
Science Citation Index Expanded |
官方审稿时间 | |
网友分享审稿时间 | 数据统计中,敬请期待。 |
PubMed Central (PML) | http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1099-498X%5BISSN%5D |
投稿指南
期刊投稿网址 | https://mc.manuscriptcentral.com/jgm-wiley |
---|---|
收稿范围 | The aims and scope of The Journal of Gene Medicine include cutting-edge science of gene transfer and its applications in gene and cell therapy, genome editing with precision nucleases, epigenetic modifications of host genome by small molecules, siRNA, microRNA and other noncoding RNAs as therapeutic gene-modulating agents or targets, biomarkers for precision medicine, and gene-based prognostic/diagnostic studies. Key areas of interest are the design of novel synthetic and viral vectors, novel therapeutic nucleic acids such as mRNA, modified microRNAs and siRNAs, antagomirs, aptamers, antisense and exon-skipping agents, refined genome editing tools using nucleic acid /protein combinations, physically or biologically targeted delivery and gene modulation, ex vivoor in vivo pharmacological studies including animal models, and human clinical trials. Papers presenting research into the mechanisms underlying transfer and action of gene medicines, the application of the new technologies for stem cell modification or nucleic acid based vaccines, the identification of new genetic or epigenetic variations as biomarkers to direct precision medicine, and the preclinical/clinical development of gene/expression signatures indicative of diagnosis or predictive of prognosis are also encouraged. |
收录体裁 | |
投稿指南 | |
投稿模板 | |
参考文献格式 | |
编辑信息 |